Protocol endomyocardial biopsy beyond 6 months—It is time to move on
Open Access
- 8 June 2020
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (2) , 825-829
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Highly Sensitive Noninvasive Cardiac Transplant Rejection Monitoring Using Targeted Quantification of Donor-Specific Cell-Free Deoxyribonucleic AcidJACC, 2014
- Usefulness of routine surveillance endomyocardial biopsy 6 months after heart transplantationThe Journal of Heart and Lung Transplantation, 2012
- Current Status of Endomyocardial BiopsyMayo Clinic Proceedings, 2011
- Gene-Expression Profiling for Rejection Surveillance after Cardiac TransplantationNew England Journal of Medicine, 2010
- Utility of Long-term Surveillance Endomyocardial Biopsy: A Multi-institutional AnalysisThe Journal of Heart and Lung Transplantation, 2006
- Nodular Endocardial Infiltrates (Quilty Lesions) Cause Significant Variability in Diagnosis of ISHLT Grade 2 and 3A Rejection in Cardiac Allograft RecipientsThe Journal of Heart and Lung Transplantation, 2005
- Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant RecipientsNew England Journal of Medicine, 2003
- A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS1Transplantation, 1998
- Natural Course of Moderate Cardiac Allograft Rejection (International Society for Heart Transplantation Grade 2) Early and Late After TransplantationCirculation, 1996
- Natural History of Focal Moderate Cardiac Allograft RejectionCirculation, 1995